Soleus Capital Management, L.P. Y M Abs Therapeutics, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.44 Billion
- Q4 2024
A detailed history of Soleus Capital Management, L.P. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 349,982 shares of YMAB stock, worth $1.75 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
349,982
Previous 399,982
12.5%
Holding current value
$1.75 Million
Previous $5.25 Million
47.82%
% of portfolio
0.19%
Previous 0.45%
Shares
11 transactions
Others Institutions Holding YMAB
# of Institutions
114Shares Held
27MCall Options Held
5.6KPut Options Held
900-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$21.2 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$14.7 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.86MShares$14.3 Million12.11% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$11 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$10 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $219M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...